Globalizar las nuevas tendencias teraputica

Our mission

become a conduit for identifying and marketing the To latest therapies in new global markets. assist our clients in accessing the latest medical and To Localizar segmentos therapeutic trends so that they can be the first movers ensear a nuestros cl in incorporating them in their portfolios. research and seek out high -value niche products in To each market and impart that knowledge to our clients, assisting them to take full advantage of such opportunities.

Our vision
remain at the cutting edge of new To developments in medical and therapeutic trends. assist our clients in identifying and taking To advantage of those opportunities which are most relevant for them given their competencies.

 knowledge base extends back more than a Our decade. Our current focus is to assist our clients in marketing new medical therapies and technologies in the Latin American market. Weve facilitated access for our clients to enter key markets which otherwise would have been daunting. group assists clients by identifying key Our products that can provide them access to new and growing markets. We stand with our clients each step of the way.

group boasts a roster of more than 60 laboratories and Our manufacturing firms, each a leader in its segment. oncology, we have positioned ourselves at the forefront of In medical innovation, sourcing and promoting key molecules like bortezomib, azacitidine, i xabepilona and imanitib. hematology, we have been focusing on leading therapies In like tirofiban, prasugrel and fingolimod. Chrions footprint can be found throughout the globe, having worked in markets as diverse as India, Europe, Mauritius, South Africa, Singapore, New Zealand, Australia, as well as various Latin American markets.

 regulatory research team is expert in the registration process Our involved in bringing a new product to a new market, adding great value by expediting the administrative process. are well versed in and keep abreast of all registration procedures We and requirements of different markets (e.g., TGA in Australia, ANVISA in Brazil, MCC in South Africa, MHRA in the United Kingdom, INVIMA in Colombia, CECMED in Cuba), vastly reducing the anticipated delays in securing the proper authorizations.

manufacturing plants and laboratories are inspected by a team of All auditors, ensuring that each meets the rigorous standards set by our group which ultimately translates to the best quality products for our clients.

 experience in identifying emerging Our medical and therapeutic trends in different markets, as well as our focus on research means that we know which products to focus on in each segment. offer a sound cost/quality proposition We which assures our client a firm foothold in growing segments that offer stellar growth opportunities.

base of operations is in Panama, the heart of Latin America, which Our offers significant synergies across different markets.

 also work closely with a number of NGOs to assist We emerging economies by helping them source quality products at a sound price. Through our affiliate network, we are able to tap inventories of generic medications, medical devices and hospital products for the benefit of our NGO clients, allowing us to provide these products in the shortest possible delays.

Chrion has also assisted various governments in Africa with their vaccination programs, tuberculosis diagnosis and awareness campaigns, sourcing and distribution of products for the treatment of AIDS, as well as offering quality primary care products.

export@chriongroup.com
Torre Capital Plaza, Urbanizacin Costa del Este. 19th Floor, Ciudad de Panam, Panam.
www.chriongroup.com